HMN 2025: How At 10 years, Roux-en-Y gastric bypass superior for affected person extra BMI loss

The long-term outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) could differ in intention-to-treat (ITT) and per protocol (PP) populations, in line with a research published on-line Feb. 19 in JAMA Surgery.

Marko Kraljevi?, M.D., from the University Hospital of Basel in Switzerland, and colleagues in contrast long-term weight and metabolic outcomes, reoperation charges, and high quality of life for sufferers at 10 years and past within the Swiss Multicenter Bypass or Sleeve Study randomized scientific trial. A complete of 217 sufferers have been enrolled and randomly assigned to SG or RYGB (107 and 110, respectively).

The researchers discovered that within the ITT inhabitants, the imply proportion extra physique mass index loss (percentEBMIL) was not considerably totally different between SG and RYGB (60.6 and 65.2, respectively). Compared with RYGB, sufferers who underwent SG had considerably increased conversion charges because of inadequate weight discount or reflux (29.9 versus 5.5%).

After 10 years, within the PP inhabitants, sufferers present process RYGB had considerably increased imply percentEBMIL in contrast with these present process SG (65.9 versus 56.1%). However, the teams didn’t considerably differ when it comes to imply proportion complete weight reduction (27.7 and 25.5% for RYGB and SG, respectively). Significantly extra de novo gastroesophageal reflux occurred in SG versus RYGB sufferers.

“For the ITT evaluation, no important distinction in percentEBMIL was discovered after 10 years evaluating SG and RYGB. However, the PP evaluation revealed superior weight loss in sufferers who underwent RYGB in comparison with SG,” the authors write.

Several authors disclosed ties to the pharmaceutical and medical machine industries.

© 2025 .